California appeals court throws out pricing case
Pharma Compliance Alert, July 30, 2008
Pfizer and 18 other pharmaceutical companies learned they will not face charges of pricing fraud in California.
The California appeals court upheld the dismissal of a 2004 lawsuit brought by pharmacies against the pharmaceutical companies. The pharmacies claimed they paid too much for drugs because the companies inflated their prices. The case was originally dismissed in 2006.
In its ruling, the court said pharmacies had already been paid for the claimed overcharges, so any additional award would be a windfall for the pharmacies.
Comments
0 comments on “California appeals court throws out pricing case ”
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Case Management Monthly, June 2012
- Searched
